SCHEDULE: Vanguard Group Discloses 5.19% Stake in Electromed Inc

The Vanguard Group has reported a 5.19% beneficial ownership stake in Electromed Inc, holding 435,637 shares of common stock as of June 30, 2025.

Summary

• The Vanguard Group, a Pennsylvania-based investment adviser, filed a Schedule 13G indicating beneficial ownership in Electromed Inc.
• As of June 30, 2025, Vanguard beneficially owned an aggregate of 435,637 shares of Electromed Inc's Common Stock.
• This ownership represents 5.19% of the total class of securities.
• Vanguard holds sole dispositive power over 425,559 shares and shared dispositive power over 10,078 shares.
• Vanguard holds shared voting power over 6,721 shares and no sole voting power.
• The filing was made pursuant to Rule 13d-1(b), classifying Vanguard as a qualified institutional investor.

Sentiment

Score: 6

Explanation: The filing is a routine disclosure of a significant passive ownership stake by a major institutional investor, which is generally viewed as a neutral to slightly positive signal of institutional confidence, but does not contain operational or financial performance data.

Positives

• Significant institutional investment from The Vanguard Group, a major asset manager, indicating a vote of confidence in Electromed Inc.
• Vanguard's ownership is held in the ordinary course of business and not for the purpose of changing or influencing control, suggesting a passive, long-term investment.

Management Comments

• The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11.

Industry Context

This filing indicates a significant passive investment by a major institutional asset manager in Electromed Inc, a company operating in the medical device sector. Such investments by large funds like Vanguard are common across various industries as part of diversified portfolio management.

Stakeholder Impact

• Shareholders: The disclosure of a significant stake by a reputable institutional investor like Vanguard may instill confidence and potentially attract other investors, signaling a vote of confidence in Electromed Inc.

Key Dates

Keywords

Electromed Inc, Vanguard Group, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Medical Devices, Healthcare